A growing number of cutaneous adverse reactions have been reported following the administration of a COVID-19 vaccine. We describe a series of twenty patients who developed a variety of cutaneous conditions within two weeks of receiving the Pfizer/ BioNTech BNT162b2 vaccine.
Keywords: Adverse effects; BNT162 vaccine; COVID-19; COVID-19 vaccines; New Zealand; dermatology; vaccination.
© 2022 Australasian College of Dermatologists.